Prof. David Kerr
JGO will be the first journal focused exclusively on cancer research, treatment, and care delivery in middle- and low-resource countries with per capita gross national incomes between $1,000 and $12,000.1 The first issue of JGO is scheduled for publication in the fall. The journal will highlight issues in global oncology in six annual issues. The publication will be online only and open access.
More than 60% of new annual cases of cancer occur in Africa, Asia, Central America, and South America, regions that account for 70% of the world’s cancer deaths,2 according to the World Health Organization.
“This journal will give a voice to oncologists in resource-constrained countries,” Prof. Kerr said.
JGO will likely include articles focusing on different countries, including those in sub-Saharan Africa, India, South America, and Southeast Asia. The publication will shed light on the particular issues each country faces regarding cancer care.
“We know that there is significant geographic variation in the types of cancer found in different regions of the world,” Prof. Kerr said. “For example, it has been estimated that half of all the world’s cases of liver cancer can be found in China.”
JGO is selecting an editorial board, with the first call for submissions scheduled for early spring. The articles will cover epidemiology, health policy, barriers to care in middle- and low-resource countries, cancer treatment, and palliative care. For the first issue, JGO will likely solicit articles from well-known experts in these fields.
All articles will go through peer review. The editorial team expects numerous submissions, especially from international contributors.
Highly Experienced Editor-in-Chief
Prof. Kerr, currently a professor of cancer medicine at the University of Oxford, in England, has published numerous peer-reviewed articles on colorectal cancer. His research encompasses drug development, gene therapy, and general medicine.
Among his many honors, Prof. Kerr is an honorary consultant medical oncologist of Oxford University Hospitals NHS Trust and an adjunct professor of medicine with Weill Cornell Medical College. He is a fellow of the Royal College of Physicians, honorary fellow of the Royal College of General Practitioners, fellow of the Academy of Medical Sciences, and fellow of the European Academy of Cancer Sciences.
Prof. Kerr is past president of the European Society of Medical Oncology and has served on many medical society international committees and working groups. He is the former editor-in-chief of Annals of Oncology and has served on the editorial boards of Nature Reviews Clinical Oncology, Japanese Journal of Clinical Oncology, Seminars in Oncology, Molecular Oncology, and Chinese Clinical Oncology.
A long-time advocate for addressing cancer in resource-constrained countries, Prof. Kerr was among the first to recognize the need for action in Africa. In 2007, he organized the first African Cancer Reform Convention in London. Shortly thereafter, he co-founded the Africa Oxford Cancer Foundation, an organization dedicated to forging partnerships with African countries to assist with implementing cancer prevention and control programs.
In his role as editor-in-chief, Prof. Kerr will explore many aspects of cancer care in resource-constrained countries for the journal‘s diverse audience.
“There’s still plenty of juice in the old lemon yet to tackle a new project of this magnitude and importance,” he said. “Together, all of us in the wider cancer community have a tremendous opportunity to make a difference.”
For additional information about JGO, please visit GlobalOncologyJournal.org.